Literature DB >> 32298026

MHC class I and II peptide homology regulates the cellular immune response.

Matthew M Halpert1, Vanaja Konduri1, Dan Liang1, Jonathan Vazquez-Perez1, Colby J Hofferek1, Scott A Weldon2, Yunyu Baig1, Indira Vedula1, Jonathan M Levitt1,3,4, William K Decker1,4,5.   

Abstract

Mammalian immune responses are initiated by "danger" signals--immutable molecular structures known as PAMPs. When detected by fixed, germline encoded receptors, pathogen-associated molecular pattern (PAMPs) subsequently inform the polarization of downstream adaptive responses depending upon identity and localization of the PAMP. Here, we report the existence of a completely novel "PAMP" that is not a molecular structure but an antigenic pattern. This pattern--the incidence of peptide epitopes with stretches of 100% sequence identity bound to both dendritic cell (DC) major histocompatibility (MHC) class I and MHC class II--strongly induces TH 1 immune polarization and activation of the cellular immune response. Inherent in the existence of this PAMP is the concomitant existence of a molecular sensor complex with the ability to scan and compare amino acid sequence identities of bound class I and II peptides. We provide substantial evidence implicating the multienzyme aminoacyl-tRNA synthetase (mARS) complex and its AIMp1 structural component as the key constituents of this complex. The results demonstrate a wholly novel mechanism by which T-helper (TH ) polarization is governed and provide critical information for the design of vaccination strategies intended to provoke cell-mediated immunity.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  AIMp1; CTLA-4; PAMP; PRR; TH1 polarization; dendritic cell

Mesh:

Substances:

Year:  2020        PMID: 32298026      PMCID: PMC7493300          DOI: 10.1096/fj.201903002R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  79 in total

1.  ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.

Authors:  Pierre Guermonprez; Loredana Saveanu; Monique Kleijmeer; Jean Davoust; Peter Van Endert; Sebastian Amigorena
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

2.  RIG-I-like Receptor Triggering by Dengue Virus Drives Dendritic Cell Immune Activation and TH1 Differentiation.

Authors:  Joris K Sprokholt; Tanja M Kaptein; John L van Hamme; Ronald J Overmars; Sonja I Gringhuis; Teunis B H Geijtenbeek
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

3.  H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection.

Authors:  W D Martin; G G Hicks; S K Mendiratta; H I Leva; H E Ruley; L Van Kaer
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

4.  GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells.

Authors:  Julie Helft; Jan Böttcher; Probir Chakravarty; Santiago Zelenay; Jatta Huotari; Barbara U Schraml; Delphine Goubau; Caetano Reis e Sousa
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

5.  A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro.

Authors:  H Navabi; B Jasani; A Reece; A Clayton; Z Tabi; C Donninger; M Mason; M Adams
Journal:  Vaccine       Date:  2008-10-31       Impact factor: 3.641

6.  Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation.

Authors:  Roger Belizaire; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-25       Impact factor: 11.205

7.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

8.  B lymphocytes secrete antigen-presenting vesicles.

Authors:  G Raposo; H W Nijman; W Stoorvogel; R Liejendekker; C V Harding; C J Melief; H J Geuze
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

9.  Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5.

Authors:  Hiroki Kato; Osamu Takeuchi; Eriko Mikamo-Satoh; Reiko Hirai; Tomoji Kawai; Kazufumi Matsushita; Akane Hiiragi; Terence S Dermody; Takashi Fujita; Shizuo Akira
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

10.  Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction.

Authors:  C Kurts; J F Miller; R M Subramaniam; F R Carbone; W R Heath
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  5 in total

1.  Immune Cluster and PPI Network Analyses Identified CXCR3 as a Key Node of Immunoregulation in Head and Neck Cancer.

Authors:  Ping Wang; Yanli Wang; Yuanjun Jiang; Minghong Li; Guang Li; Qiao Qiao
Journal:  Front Oncol       Date:  2021-01-15       Impact factor: 6.244

Review 2.  CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential.

Authors:  Vanaja Konduri; Damilola Oyewole-Said; Jonathan Vazquez-Perez; Scott A Weldon; Matthew M Halpert; Jonathan M Levitt; William K Decker
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

Review 3.  Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types.

Authors:  Damilola Oyewole-Said; Vanaja Konduri; Jonathan Vazquez-Perez; Scott A Weldon; Jonathan M Levitt; William K Decker
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

4.  Changes in the Proteome in the Development of Chronic Human Papillomavirus Infection-A Prospective Study in HIV Positive and HIV Negative Rwandan Women.

Authors:  Emile Bienvenu; Marie Francoise Mukanyangezi; Stephen Rulisa; Anna Martner; Bengt Hasséus; Egor Vorontsov; Gunnar Tobin; Daniel Giglio
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

Review 5.  Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?

Authors:  Michael Kuske; Maximilian Haist; Thomas Jung; Stephan Grabbe; Matthias Bros
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.